These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
53 related items for PubMed ID: 27383579
1. Incidence and risk factors of fever in a contemporary cohort of HIV-patients with good access to antiretroviral therapy. De Munter P, Derdelinckx I, Peetermans WE, Fieuws S, Vanderschueren S, Van Wijngaerden E. Acta Clin Belg; 2017 Aug; 72(4):226-231. PubMed ID: 27383579 [Abstract] [Full Text] [Related]
3. Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: role of antiretroviral therapy. Masiá M, Padilla S, Álvarez D, López JC, Santos I, Soriano V, Hernández-Quero J, Santos J, Tural C, del Amo J, Gutiérrez F, CoRIS. AIDS; 2013 Jan 14; 27(2):181-9. PubMed ID: 23018442 [Abstract] [Full Text] [Related]
4. No change in viral set point or CD4 cell decline among antiretroviral treatment-naïve, HIV-1-infected individuals enrolled in the Danish HIV Cohort Study in 1995-2010. Helleberg M, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Obel N, Gerstoft J. HIV Med; 2013 Jul 14; 14(6):362-9. PubMed ID: 23433434 [Abstract] [Full Text] [Related]
5. Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort. Grabar S, Tattevin P, Selinger-Leneman H, de La Blanchardiere A, de Truchis P, Rabaud C, Rey D, Daneluzzi V, Ferret S, Lascaux AS, Hanslik T, Costagliola D, Launay O, French Hospital Database on HIV (FHDH-ANRS CO4 Cohort). Clin Infect Dis; 2015 Apr 15; 60(8):1269-77. PubMed ID: 25601456 [Abstract] [Full Text] [Related]
15. Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India. Alvarez-Uria G, Pakam R, Midde M, Naik PK. J Int AIDS Soc; 2014 Apr 15; 17(1):19251. PubMed ID: 25499123 [Abstract] [Full Text] [Related]
17. Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts. Mocroft A, Staszewski S, Weber R, Gatell J, Rockstroh J, Gasiorowski J, Panos G, Monforte Ad, Rakhmanova A, Phillips AN, Lundgren JD, EuroSIDA study group. Antivir Ther; 2007 Apr 15; 12(3):325-33. PubMed ID: 17591022 [Abstract] [Full Text] [Related]
18. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. Mocroft A, Phillips AN, Gatell J, Ledergerber B, Fisher M, Clumeck N, Losso M, Lazzarin A, Fatkenheuer G, Lundgren JD, EuroSIDA study group. Lancet; 2007 Aug 04; 370(9585):407-13. PubMed ID: 17659333 [Abstract] [Full Text] [Related]
19. Risk of cancers during interrupted antiretroviral therapy in the SMART study. Silverberg MJ, Neuhaus J, Bower M, Gey D, Hatzakis A, Henry K, Hidalgo J, Lourtau L, Neaton JD, Tambussi G, Abrams DI. AIDS; 2007 Sep 12; 21(14):1957-63. PubMed ID: 17721103 [Abstract] [Full Text] [Related]
20. Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort. Hleyhel M, Belot A, Bouvier AM, Tattevin P, Pacanowski J, Genet P, De Castro N, Berger JL, Dupont C, Lavolé A, Pradier C, Salmon D, Simon A, Martinez V, Costagliola D, Grabar S, French Hospital Database on HIV–ANRS CO4 Cohort. Clin Infect Dis; 2013 Dec 12; 57(11):1638-47. PubMed ID: 23899679 [Abstract] [Full Text] [Related] Page: [Next] [New Search]